Pathogenesis and Therapy of Muscular Dystrophies
A Special Issue of International Journal of Molecular Sciences (ISSN 1422-0067) belonging to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 436
Editor
Special Issue Information
Dear Colleagues,
Muscular dystrophies comprise a heterogeneous group of genetic diseases causing progressive muscle weakness, sometimes associated with cardiac, respiratory or even central nervous system involvement. The mode of transmission may be autosomal dominant or recessive, X-linked or due to a repeat expansion or contraction and the age of onset varies from neonatal to adulthood. Over the last few years, there has been an impressive breakthrough in the area of genetics, leading to the characterization of the responsible gene defect of an ever-increasing number of muscular dystrophies. This characterization led to the elucidation of the underlying pathogenesis and eventually to the approval of the first targeted therapies.
The aim of this Special Issue of the International Journal of Molecular Sciences (IJMS) entitled “Pathogenesis and Therapy of Muscular Dystrophies” is to further indulge in current progress in the field of pathogenesis and treatment of muscular dystrophies. Since IJMS is a journal of molecular science, pure clinical studies are not suitable for our journal. However, clinical or pure model submissions with biomolecular experiments are welcomed.
Dr. Constantinos Papadopoulos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- muscular dystrophy
- pathogenesis
- pathophysiology
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
